- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Complement-Dependent Action of HLA-Specific Antibodies on Human Platelets ; volume:38 ; number:02 ; year:1977
Konferenz: VIth International Congress on Thrombosis and Haemostasis; 1977-06-27
Thrombosis and haemostasis ; 38, Heft 02 (1977)
- Beteiligte Personen und Organisationen
-
Heinrich, D.
Mueller-Eckhardt, C.
Bitter-Suermann, D.
- DOI
-
10.1055/s-0039-1682710
- URN
-
urn:nbn:de:101:1-2019061208111179683617
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heinrich, D.
- Mueller-Eckhardt, C.
- Bitter-Suermann, D.
Ähnliche Objekte (12)
Ionophoretic Action of Phospholipids on Human Platelets
Procoagulant Platelets: Mechanisms of Generation and Action
Large-scale production of HLA-silenced megakaryocytes and platelets for universal application
The Role of Complement and Platelets in the Dissolution of Thrombin-Induced Clots
Complement Dependent and Independent Effects of Bacterial Products on Rabbit and Human Platelets
Monoclonal antibodies against the fifth component of human complement
Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
Detection of human B cells secreting HLA antibodies by ELISpot
Separation of Degranulated Platelets from Normal Platelets
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy
Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae
Ionophoretic Action of Phospholipids on Human Platelets
Procoagulant Platelets: Mechanisms of Generation and Action
Large-scale production of HLA-silenced megakaryocytes and platelets for universal application
The Role of Complement and Platelets in the Dissolution of Thrombin-Induced Clots
Complement Dependent and Independent Effects of Bacterial Products on Rabbit and Human Platelets
Monoclonal antibodies against the fifth component of human complement
Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
Detection of human B cells secreting HLA antibodies by ELISpot
Separation of Degranulated Platelets from Normal Platelets
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy
Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae
Ionophoretic Action of Phospholipids on Human Platelets
Procoagulant Platelets: Mechanisms of Generation and Action
Large-scale production of HLA-silenced megakaryocytes and platelets for universal application
The Role of Complement and Platelets in the Dissolution of Thrombin-Induced Clots
Complement Dependent and Independent Effects of Bacterial Products on Rabbit and Human Platelets
Monoclonal antibodies against the fifth component of human complement
Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
Detection of human B cells secreting HLA antibodies by ELISpot
Separation of Degranulated Platelets from Normal Platelets
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy